Jason Paronish
Family · Camp Hill, PANPI 1275316200
Payments from drug & device makers
Across 75 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$225
- Lilly USA, LLC$219
- Exact Sciences$136
- AbbVie$107
- Phathom Pharmaceuticals, Inc.$75
- AstraZeneca$70
- plus $477 from 14 others
What the payments were for
- Food & beverage$1,309100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 13 | $225 |
| Lilly USA, LLC | 12 | $219 |
| Exact Sciences | 8 | $136 |
| AbbVie | 5 | $107 |
| Phathom Pharmaceuticals, Inc. | 5 | $75 |
| AstraZeneca | 4 | $70 |
| Pfizer | 4 | $65 |
| Otsuka America Pharmaceutical, Inc. | 4 | $63 |
| Lundbeck LLC | 3 | $60 |
| GSK | 3 | $46 |
| Amgen | 3 | $46 |
| Biogen | 2 | $37 |
| Cequr Corporation | 1 | $36 |
| Novartis | 2 | $35 |
| Boehringer Ingelheim | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
| Seqirus USA Inc | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
How this compares
$1,309 in reported general payments places this provider in the 75th percentile of 4,717 family providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 23 | $1,529 |
| Doxycycline Hyclate | 57 | $948 |
| Divalproex Sodium | 15 | $703 |
| Tramadol Hcl | 40 | $558 |
| Quetiapine Fumarate | 14 | $397 |
| Escitalopram Oxalate | 20 | $277 |
| Ipratropium-AlbuterolIpratropium/Albuterol Sulfate | 14 | $208 |
| Sertraline Hcl | 30 | $207 |
| Ciprofloxacin Hcl | 26 | $173 |
| Midodrine Hcl | 11 | $173 |
| Hydralazine Hcl | 20 | $169 |
| Amlodipine Besylate | 20 | $161 |
| Lisinopril | 40 | $140 |
| Fluticasone Propionate | 13 | $137 |
| Methylprednisolone | 13 | $93 |
Paid to pharmacies, not to this prescriber.
Other family in Camp Hill
- Stephanie HarshbargerCamp Hill$317K
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.